Clinical Trial Update: Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases [Phase 2]

View source ↗

Summary

This Phase 2 trial compares Adecatumumab to the FOLFOX regimen after complete surgical resection of colorectal liver metastases; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Adecatumumab (adecatumumab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Amgen Research (Munich) GmbH | Conditions: Liver Metastases, Colorectal Cancer | Phase 2 | Status: COMPLETED